TherapeuticsMD (TXMD) Cash from Discontinued Operations (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Cash from Discontinued Operations came in at 8000.0 in Q1 2026, up 38.46% YoY from 5777.78 in Q1 2025, and down 14.29% on a QoQ basis from 7000.0 in Q4 2025.
TherapeuticsMD (TXMD) Cash from Discontinued Operations (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 6 years of Cash from Discontinued Operations data on file, last reported at 8000.0 in Q1 2026.
- Quarterly Cash from Discontinued Operations rose 38.46% year-over-year to 8000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 25000.0 (up 96.38% YoY) and the FY2025 annual result came in at 30000.0, up 93.15% from the prior year.
- Cash from Discontinued Operations eased to 8000.0 in Q1 2026, from 7000.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 136529000.0 in Q2 2022 to a low of 131010000.0 in Q4 2022.
- A 5-year average of 2292529.41 and a median of 57000.0 in 2025 frame the typical range for Cash from Discontinued Operations.
- The widest YoY moves for Cash from Discontinued Operations: up 148.93% in 2023, down 110.01% in 2023.
- Tracing TXMD's Cash from Discontinued Operations over 5 years: stood at 131010000.0 in 2022, then jumped by 97.8% to 2881000.0 in 2023, then soared by 99.83% to 5000.0 in 2024, then sank by 40.0% to 7000.0 in 2025, then decreased by 14.29% to 8000.0 in 2026.
- The last three Cash from Discontinued Operations figures came in at 8000.0 (Q1 2026), 7000.0 (Q4 2025), and 47000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | -9,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9,000.00 |
| Jun 30, 2026 | -9,000.00 |
| Mar 31, 2026 | -8,000.00 |
| Mar 31, 2026 | -8,000.00 |
| Dec 31, 2025 | -7,000.00 |
| Dec 31, 2025 | -7,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | -57,000.00 |
| Jun 30, 2025 | -57,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Sep 30, 2024 | -114,000.00 |
| Sep 30, 2024 | -114,000.00 |
| Jun 30, 2024 | -559,000.00 |
| Jun 30, 2024 | -559,000.00 |
| Mar 31, 2024 | 240,000.00 |
| Mar 31, 2024 | 240,000.00 |